4//SEC Filing
Lister Troy 4
Accession 0000950170-24-077410
CIK 0001840574other
Filed
Jun 24, 8:00 PM ET
Accepted
Jun 25, 5:05 PM ET
Size
5.4 KB
Accession
0000950170-24-077410
Insider Transaction Report
Form 4
Lister Troy
Chief Scientific Officer
Transactions
- Award
Stock Option (right to buy)
2024-06-21+32,000→ 32,000 totalExercise: $5.29Exp: 2034-06-20→ Common Stock (32,000 underlying)
Footnotes (1)
- [F1]The option was granted on June 21, 2024. 25% of the shares underlying the option will vest on June 21, 2025, and the remainder are scheduled to vest in equal monthly installments thereafter until June 21, 2028.
Documents
Issuer
Verve Therapeutics, Inc.
CIK 0001840574
Entity typeother
Related Parties
1- filerCIK 0002023489
Filing Metadata
- Form type
- 4
- Filed
- Jun 24, 8:00 PM ET
- Accepted
- Jun 25, 5:05 PM ET
- Size
- 5.4 KB